Mogwai, Any Projections Concerning Script Growth
whether positive or negative are just speculations.
All I know is that script rate currently appears to be growing at a very slow rate and doubling or tripling the current script rate will take a very long time (years) at the current growth rate.
IMO if script growth doesn't start accelerating soon, dilution will be needed in late 2016.
But other have provided financial analyses indicating dilution may not be needed IF certain things happen (i.e. reduced expenses, Amarin Management starts buying the stock with their own money, international approvals, injection of cash by potential partners, Martians land and decide Vascepa is great for intergalactic travel, etc.).
No sense getting your knickers in a twist either way since no one on this board really knows what will actually happen over the next year.
Market Data 
Markets 
AI
